# Short-term effects of a 12-week Zumba program on thyroid and cardiometabolic markers in overweight/obese postmenopausal women: A randomized pilot study

**Authors:** Hanen Saadouni, Okba Selmi, Nejmeddine Ouerghi, Hamza Marzouki, Soukaina Hattabi, Lamia Attig, Katja Weiss, Thomas Rosemann, Beat Knechtle, Anissa Bouassida

PMC · DOI: 10.1016/j.clinsp.2026.100880 · Clinics · 2026-02-19

## TL;DR

A 12-week Zumba program improved thyroid and heart health in overweight postmenopausal women, offering a non-drug way to boost their well-being.

## Contribution

This study shows Zumba as a feasible, enjoyable non-pharmacological strategy to improve cardiometabolic and thyroid health in postmenopausal women.

## Key findings

- Zumba significantly reduced TSH and triglyceride levels in postmenopausal women.
- The program improved body composition and blood pressure in participants.
- No significant changes were observed in the control group.

## Abstract

•Zumba lowers TSH and triglycerides in postmenopausal obese women.•Zumba improves body composition and blood pressure after menopause.•Zumba is a non-drug strategy to boost postmenopausal women's health.•Dance-based training helps regulate thyroid and lipid levels postmenopause.

Zumba lowers TSH and triglycerides in postmenopausal obese women.

Zumba improves body composition and blood pressure after menopause.

Zumba is a non-drug strategy to boost postmenopausal women's health.

Dance-based training helps regulate thyroid and lipid levels postmenopause.

This pilot study aimed to investigate the effects of a 12-week Zumba training program on Thyroid-Stimulating Hormone (TSH), Free Thyroxine (FT4), lipid profile, and anthropometric parameters in overweight and obese postmenopausal women.

Twenty-two women (aged 44‒60 years) were randomly assigned to a Zumba training group (ZG; n = 11) or a control group (CG; n = 11). The ZG participated in 60-min Zumba sessions three times per week for 12-weeks, while the CG maintained their usual lifestyle. Before and after the intervention, participants underwent assessments of body composition, blood pressure, and circulating levels of TSH, FT4, Total Cholesterol (TC), and Triglycerides (TG).

Following the intervention, the ZG showed significant reductions in TSH (p = 0.001; Cohen’s d (d) = 0.90), TG levels (p = 0.043; d = 0.75), body fat percentage, body mass index, waist and hip circumference, and both systolic and diastolic blood pressure (all p < 0.05). No significant changes were observed for FT4 and TC levels. No notable changes were recorded in the CG.

The 12-week Zumba program can serve as a feasible and enjoyable strategy for promoting physical activity in overweight and obese postmenopausal women, leading to improvements in thyroid function, TG levels, body composition, and blood pressure. These preliminary findings support the potential of Zumba for enhancing cardiometabolic health during menopause, though larger, long-term trials are needed to confirm these effects and investigate their durability.

## Linked entities

- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Genes:** LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, TRH (thyrotropin releasing hormone) [NCBI Gene 7200] {aka Pro-TRH, TRF}, HPT (hypoparathyroidism) [NCBI Gene 3258] {aka HPTX, HYPX}
- **Diseases:** insulin resistance (MESH:D007333), anxiety (MESH:D001007), cardiovascular disease (MESH:D002318), diabetes mellitus (MESH:D003920), thyroid insufficiency (MESH:D000309), endocrine disorders (MESH:D004700), hypertension (MESH:D006973), hematologic disturbances (MESH:D006402), hypothyroidism (MESH:D007037), inflammation (MESH:D007249), cognitive impairment (MESH:D003072), memory loss (MESH:D008569), neuromuscular disorders (MESH:D009468), overweight (MESH:D050177), thyrocyte dysfunction (MESH:D006331), type 2 diabetes (MESH:D003924), thyroid disease (MESH:D013959), autoimmune (MESH:D001327), hypercholesterolemia (MESH:D006937), obese (MESH:D009765), depression (MESH:D003866), adiposity (MESH:D018205)
- **Chemicals:** TG (MESH:D014280), lactate (MESH:D019344), estradiol (MESH:D004958), FT4 (-), T4 (MESH:D013974), thyroid-stimulating hormone (MESH:D013972), Melatonin (MESH:D008550), Cholesterol (MESH:D002784), progesterone (MESH:D011374), T3 (MESH:D014284), heparin (MESH:D006493), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933445/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933445/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933445/full.md

---
Source: https://tomesphere.com/paper/PMC12933445